Tango Therapeutics to Report Second Quarter 2025 Financial Results on Tuesday, August 5, 2025

Company Overview - Tango Therapeutics, Inc. is a clinical-stage biotechnology company focused on discovering novel drug targets and advancing precision medicine for cancer treatment [2] - The company employs the genetic principle of synthetic lethality to develop therapies targeting critical cancer-related targets [2] Financial Announcement - Tango Therapeutics will report its second quarter 2025 financial results on August 5, 2025, before the U.S. financial markets open [1] - The company has stated that it will not hold a conference call following the financial results announcement [1]